These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 7357533)

  • 1. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells.
    Zbar B; Canti G; Rapp HJ; Ashley MP; Sukumar S; Bast RC
    Cancer Res; 1980 Apr; 40(4):1036-42. PubMed ID: 7357533
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.
    Sparks FC; Breeding JH
    Cancer Res; 1974 Dec; 34(12):3262-9. PubMed ID: 4471640
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages.
    Harmel RP; zbar B
    J Natl Cancer Inst; 1975 Apr; 54(4):989-92. PubMed ID: 1127729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
    Jessup JM; Riggs CW; Hanna MG
    Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination of active and passive immunization and chemotherapy to transplantation of methylcholanthrene-induced tumor in WKA rats.
    Gotoda E; Sendo F; Hosokawa M; Kodama T; Kobayashi H
    Cancer Res; 1974 Aug; 34(8):1947-51. PubMed ID: 4842248
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

  • 10. Alteration of immunogenicity of xenogenized tumor cells in syngeneic rats by the immune responses to virus-associated antigens produced on immunizing cells.
    Hosokawa M; Okayasu T; Ikeda K; Katoh H; Suzuki Y; Kobayashi H
    Cancer Res; 1983 May; 43(5):2301-5. PubMed ID: 6831454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to soluble tumor antigens in various stages of tumor growth.
    Brannen GE; Santos GW
    Invest Urol; 1975 Sep; 13(2):79-84. PubMed ID: 1184342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.
    Pellis NR; Tom BH; Kahan BD
    J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043
    [No Abstract]   [Full Text] [Related]  

  • 13. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
    Vaage J
    Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
    Hanna MG; Peters LC
    Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common tumor rejection antigens in methylcholanthrene-induced squamous cell carcinomas of mice detected by tumor protection and a radioisotopic footpad assay.
    Economou GC; Takelchi N; Boone CW
    Cancer Res; 1977 Jan; 37(1):37-41. PubMed ID: 63329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunobiological properties of 1-butanol-extracted cell surface antigens.
    LeGrue SJ; Allison JP; Macek CM; Pellis NR; Kahan BD
    Cancer Res; 1981 Oct; 41(10):3956-60. PubMed ID: 7026027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma.
    Liotta LA; Kleinerman J; Saidel GM
    Cancer Res; 1976 Sep; 36(9 pt.1):3255-9. PubMed ID: 788897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of tumor antigen on maintenance versus depression of tumor-specific immunity.
    Vaage J
    Cancer Res; 1973 Mar; 33(3):493-503. PubMed ID: 4689898
    [No Abstract]   [Full Text] [Related]  

  • 20. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
    Kataoka T; Tokunaga T; Murohashi T
    J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.